6550--NEW - STX Core Lab QC Consumables

02, San Antonio, TX 78240 Requiring Activity South Texas Veterans Health Care System (STVHCS) Pathology & Laboratory Medicine Service Place of Performance Audie L. Murphy VA Hospital, San Antonio, TX 78229; Kerrville VA Medical Center, Kerrville, TX 78028 NAICS Code 325413 In-Vitro Diagnostic Substance Manufacturing (Size Standard: 1,250 employees) Product Service Code (PSC) 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits, and Sets Procurement Vehicle Open Market Full and Open Competition (no GSA Schedule, BPA, or other contract vehicle) Set-Aside None Unrestricted; SDVOSB / VOSB participation evaluated as a non-price factor under VAAR 815.304-71 Contract Type Single-Award Indefinite-Delivery, Indefinite-Quantity (IDIQ) with Firm-Fixed-Price delivery orders (FAR 16.504; FAR 16.202) Ordering Period Base ordering period of twelve (12) months plus four (4) twelve-month option periods (5 years total, not to exceed FAR 17.204(e)) Estimated Maximum Ceiling $1,310,704.58 (inclusive of base and all option periods) Acquisition Authority FAR Part 12 (Commercial Products and Services); FAR Part 13 / FAR Part 15 as applicable; FAR 11.104 and FAR 52.211-6 (Brand Name or Equal); VAAR Parts 811, 815, and 819 Response Date / Time Friday, May 8, 2026, 10:00 AM Central Time (CT) Response Method Email submission to the Contracting Officer / Contract Specialist identified below; subject line: "RFQ 36C25726Q0381 Quotation [Offeror Name]" Questions Due Friday, May 1, 2026, 2:00 PM Central Time (CT) written questions only, via email Anticipated Award Date On or about Monday, June 1, 2026 (subject to availability of funds) FOB / Delivery FOB Destination, both sites; next-business-day delivery from receipt of order Primary Point of Contact Ognian D. Ivanov, Contract Specialist ognian.ivanov@va.gov 1. Notice and Acquisition Authority This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a separate written solicitation will not be issued. This acquisition is conducted under the authority of FAR Part 12 (Acquisition of Commercial Products and Commercial Services), in conjunction with the simplified procedures of FAR Part 13 and the negotiated procedures of FAR Part 15 as applicable. The associated North American Industry Classification System (NAICS) code is 325413, In-Vitro Diagnostic Substance Manufacturing, with a small business size standard of 1,250 employees. The associated Product Service Code (PSC) is 6550. This solicitation document and incorporated provisions and clauses are those in effect through the most recent Federal Acquisition Circular (FAC) and VA Acquisition Regulation (VAAR) supplement in effect on the date of this notice. 2. Description of the Requirement The Department of Veterans Affairs, South Texas Veterans Health Care System (STVHCS) Pathology & Laboratory Medicine Service, has a recurring requirement for in-vitro diagnostic (IVD) quality-control (QC) reagents and consumables, and for the renewal of the associated QC data-management software, in support of the Core Laboratory at the Audie L. Murphy VA Hospital (San Antonio, TX) and the Kerrville VA Medical Center (Kerrville, TX). The QC materials and software directly support patient testing performed under the Clinical Laboratory Improvement Amendments (CLIA) on the installed Beckman Coulter AU 5800 (clinical chemistry), Beckman Coulter DxI 800 (immunoassay), and Tosoh HbA1c analyzer fleet. The Government intends to award a single-award Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract under FAR 16.504, against which Firm-Fixed-Price delivery orders will be issued. The contract will include a base ordering period of twelve (12) months and four (4) twelve-month option periods, for a total ordering time not to exceed five (5) years (FAR 17.204(e)). The maximum contract ceiling is $1,310,704.58 inclusive of the base and all option periods. A guaranteed minimum obligation will be stated in Section B of the solicitation and satisfied via an initial delivery order issued upon award. 3. Brand Name or Equal FAR 11.104 / FAR 52.211-6 This acquisition is solicited on a Brand Name or Equal basis pursuant to FAR 11.104 and includes provision FAR 52.211-6, Brand Name or Equal (AUG 1999). The brand name referenced is Bio-Rad Laboratories, Inc. The Brand Name or Equal Justification supporting this acquisition is posted with this notice as Attachment 3. Offerors may quote the referenced Bio-Rad brand-name products listed below, or may quote an "equal" product that meets each of the salient physical, functional, and performance characteristics set forth in Attachment 2 Salient Characteristics. Offerors quoting an "equal" product shall complete and submit the Compliance Matrix at Attachment 5 with their quotation, together with the substantiating documentation identified in Part VII of Attachment 2 (FDA 510(k) clearance, Instructions for Use, commutability data, VA TRM listing and Section 508 / VPAT documentation for software, and a delivery / lead-time statement). Brand-name products referenced (in the alternative): Brand-Name Reference (Bio-Rad Laboratories, Inc.) SOW Item(s) Multiqual Levels 1 / 2 / 3 (tri-level clinical chemistry QC) Items 1 3 Liquichek Immunoassay Plus Levels 1 / 2 / 3 Items 4 6 Liquichek Ethanol / Ammonia Control Levels 1 / 2 / 3 Items 7 9 Liquichek Cardiac Marker Plus LT Levels 1 / 2 / 3 Items 10 12 Liquichek Diabetes Control (HbA1c) Levels 1 / 2 / 3 Items 13 15 Liquichek Urine Chemistry Levels 1 / 2 Items 16 17 Liquichek Immunology Levels 1 / 2 / 3 Items 18 20 Liquichek Spinal Fluid Levels 1 / 2 Items 21 22 Liquichek Urine Toxicology Screen S1E / S2E (Low Opiate) Items 23 24 Liquichek Cardiac Markers Plus LT Level 1B Item 25 Liquichek Specialty Immunoassay Plus Levels 1 / 2 / 3 Items 26 28 Unity Real Time QC Data-Management Software (12-month subscription) Item 29 4. Procurement Vehicle, Set-Aside Status, and Veteran Small Business Participation This requirement is being acquired on the Open Market under full and open competition. The Government is not soliciting against the General Services Administration (GSA) Federal Supply Schedule, the VA Federal Supply Schedule (FSS), a Blanket Purchase Agreement (BPA), a Government-wide Acquisition Contract (GWAC), or any other pre-existing contract vehicle. Quotations from any responsible source, including non-Schedule holders, are solicited and will be evaluated on an equal basis. Following review of the market research consolidated in Attachment 1A (Market Research Report) and consistent with the "Rule of Two" analysis under VAAR 819.7005 and 38 U.S.C. § 8127, this acquisition is issued on an unrestricted basis. The Contracting Officer determined that two or more verified Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) or Veteran-Owned Small Businesses (VOSBs) capable of performing at fair and reasonable prices were not identified for the consolidated multi-analyzer / multi-platform requirement at the maximum ceiling stated above. Notwithstanding the unrestricted status of this acquisition, SDVOSB and VOSB participation will be evaluated as a non-price factor under Section M of the solicitation, consistent with